Source · Select Committees · Home Affairs Committee
Recommendation 50
50
Paragraph: 175
Ensure sustainable supply of prescribed diamorphine for patients facing shortages.
Recommendation
We are concerned by reported shortages of prescribed diamorphine, particularly because of the serious impact they may have on the health and lives of patients. As prescribed diamorphine is a viable form of treatment in England, the Government must work with suppliers to ensure that a sustainable supply is available to patients whom clinicians deem suitable for it.
Paragraph Reference:
175
Government Response
A response document is linked to this report, dated 14 November 2023. Response attribution to this recommendation has not been verified. Read the response document ↗